<DOC>
	<DOCNO>NCT00118482</DOCNO>
	<brief_summary>The main question study whether people take fludrocortisone less likely faint people take inactive pill call placebo . Fludrocortisone drug stimulates body retain salt water . The investigator know study might prevent people faint home community , carry life . There evidence salt water retention help prevent fainting , one clear idea whether true . This study try determine true .</brief_summary>
	<brief_title>Clinical Trial Prevention Vasovagal Syncope</brief_title>
	<detailed_description>About 10 % adult faint recurrently . These patient often highly symptomatic , problem employment driving , well-documented reduce quality life . There therapy withstand test adequately conduct credible randomized clinical trial . There ample evidence importance blood volume pathophysiology vasovagal syncope . Fludrocortisone acetate corticosteroid mild enhancement glucocorticoid activity mark increase mineralocorticoid activity . It appreciable glucocorticoid effect dose 0.05 0.2 mg , commonly use clinical dos various disorder require mineralocorticoid adrenal replacement . The acute action fludrocortisone acetate sodium water retention , expense urinary potassium excretion . Blood volume expansion either dietary salt supplementation fludrocortisone often recommend clinician treatment vasovagal syncope despite paucity good evidence efficacy . Four clinical study suggest utility prevention syncope . Fludrocortisone might decrease incidence vasovagal syncope , quality evidence support use poor . There randomize , placebo-controlled trial fludrocortisone prevention vasovagal syncope . In 5-year study investigator test hypothesis fludrocortisone prevents recurrences vasovagal syncope .</detailed_description>
	<mesh_term>Syncope</mesh_term>
	<mesh_term>Syncope , Vasovagal</mesh_term>
	<mesh_term>Fludrocortisone</mesh_term>
	<criteria>Syncope cause loss consciousness accord European Society Cardiology criterion &gt; 2 lifetime syncopal spell precede enrollment &gt; = 2 point Syncope Symptom Score Structurally Normal Hearts Age &gt; 18 year informed consent , age &gt; 14 year consent inform parental consent Other cause syncope , ventricular tachycardia , complete heart block , postural ( orthostatic ) hypotension hypersensitive carotid sinus syndrome An inability give inform consent Important valvular , coronary , myocardial conduction abnormality significant arrhythmia Hypertrophic cardiomyopathy A known intolerance fludrocortisone Another clinical need fludrocortisone meet drug A permanent pacemaker A seizure disorder A major chronic non cardiovascular disease Hypertension ( blood pressure â‰¥ 130/85 2 occasion ) heart failure Renal dysfunction ( baseline glomerular filtration rate reduce 60 ml/min/1.73m2 accord CockroftGault formula ) Diabetes mellitus Hepatic disease Glaucoma Any prior use fludrocortisone acetate A 5minute stand test result diagnosis postural orthostatic tachycardia syndrome orthostatic hypotension</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>vasovagal syncope</keyword>
	<keyword>randomize clinical trial</keyword>
	<keyword>quality life</keyword>
</DOC>